Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis

Published:2019-05-06 Issue:7 Volume:31 Page:692-697
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Carubbi Francesco¹²,Fidanza Rosaria²³,Palmieri Maria⁴,Ventura Alessandra⁴,Tambone Sara⁴,Cipriani Paola¹,Giacomelli Roberto¹,Fargnoli Maria Concetta⁴

Affiliation:

1. Rheumatology Unit, Department of Biotechnological and Applied Clinical Science, School of Medicine, University of L'Aquila, L'Aquila, Italy;

2. Department of Medicine, ASL1 Avezzano-Sulmona-L’Aquila, L’Aquila, Italy;

3. San Salvatore Hospital, UOSD Dermatologia, L’Aquila, Italy;

4. Dermatology Department, Department of Biotechnological and Applied Clinical Science, School of Medicine, University of L'Aquila, L'Aquila, Italy

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2019.1605143

Reference29 articles.

1. Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence

2. Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: the experience of two Italian integrated Dermatology/Rheumatology outpatient clinics

3. Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies

4. Psoriatic Arthritis

5. New Insights into the Concept of Psoriatic Disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group;International Journal of Dermatology;2024-05-12

2. [Translated article] Risk-sharing agreement based on health outcomes for the treatment of moderate–severe psoriasis with certolizumab pegol;Farmacia Hospitalaria;2023-12

3. Acuerdo de riesgo compartido basado en resultados de salud para el tratamiento de psoriasis moderada-grave con certolizumab pegol;Farmacia Hospitalaria;2023-09

4. Certolizumab Pegol Use in the Treatment of Moderate-to-Severe Psoriasis: Real-World Data From Two Canadian Centers;Journal of Cutaneous Medicine and Surgery;2022-02-08

5. Certolizumab pegol in the treatment of psoriasis: Real‐life data;Dermatologic Therapy;2021-03-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3